Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2009-014176-22-HU
EUCTR2009-014176-22-HUActive, not recruitingNot Applicable

A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADF

Eli Lilly0 sites4,100 target enrollmentStarted: October 7, 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Eli Lilly
Enrollment
4,100
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •NSTEMI with elevated troponin
  • •Scheduled for early coronary angiography and PCI
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •Cardiogenic shock at time of randomisation
  • •refractory ventricular arrhythmias
  • •congestive heart failure
  • •cardiac arrest
  • •prior TIA or stroke
  • •active pathological bleeding
  • •severe hepatic impairment

Investigators

Sponsor
Eli Lilly

Similar Trials

Active, not recruiting
Phase 1
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 14.0Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-SKEli Lilly4,100
Active, not recruiting
Not Applicable
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI): The ACCOAST Study - ACCOASTAcute Coronary SyndromesMedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-PLEli Lilly and Company4,100
Active, not recruiting
Not Applicable
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADF
EUCTR2009-014176-22-DKEli Lilly4,100
Active, not recruiting
Phase 1
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 13.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-BEEli Lilly4,100
Active, not recruiting
Not Applicable
A Comparison of Prasugrel at the Time of Percutaneous Coronary Intervention (PCI) Or as Pre-treatment At the Time of Diagnosis in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) - The ACCOAST Study - TADFAcute Coronary SyndromesMedDRA version: 14.1Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2009-014176-22-FIEli Lilly4,100